Your email has been successfully added to our mailing list.

×
0 0.04 0.00400000000000009 0.00400000000000009 0.00400000000000009 0.00400000000000009 0.00400000000000009 0.00400000000000009
Stock impact report

Vertical Pharmaceuticals, LLC, an Osmotica Company, Announces Acceptance of New Drug Application by FDA for RVL-1201 (Oxymetazoline Hydrochloride Ophthalmic Solution, 0.1%) for Acquired Bl...

Osmotica Pharmaceuticals plc - Ordinary Shares (OSMT) 
Last osmotica pharmaceuticals plc - ordinary shares earnings: 3/18 04:05 pm Check Earnings Report
Company Research Source: GlobeNewswire
BRIDGEWATER, N.J., Nov. 20, 2019 (GLOBE NEWSWIRE) -- Vertical Pharmaceuticals, LLC (a subsidiary of Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company) today announced that the Company received notification that the New Drug Application (“NDA”) for RVL-1201 (“RVL”) for Acquired Blepharoptosis (droopy eyelid or ptosis) has been filed by the U.S. Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (PDUFA) goal date of July 16, 2020. “We are delighted that our NDA has been accepted for filing. Today, there are no pharmacologic options approved for treatment of droopy eyelid.  If approved, RVL would offer physicians and patients a therapeutic option for the treatment of ptosis supported by compelling safety and efficacy data from three well-controlled pivotal studies. With the simplicity of using a once-daily eye drop, RVL has the potential to transform the clinical treatment of acquired ble Show less Read more
Impact Snapshot
Event Time:
OSMT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for OSMT alerts
Opt-in for
OSMT alerts

from News Quantified
Opt-in for
OSMT alerts

from News Quantified